cell pharm GmbH Company Profile

12:58 EDT 1st July 2015 | BioPortfolio



Email: info@cellpharm.com

News Articles [1069 Associated News Articles listed on BioPortfolio]

Chinese regulator approves D-Pharm epilepsy drug trial

D-Pharm has teamed with China's Nhwa Pharmaceutical in developing DP-VPA.

Bukwang Pharm Appoints Korea's First Woman CEO

Yu Hee-won has been appointed as co-president and CEO of Korean-based Bukwang Pharm.

Re-Pharm identifies novel anti-inflammatory activity for existing compound

Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce the identification of RP0217 as an effective new anti-inflammat...

University of Florida's Pharm.D. program highlights risks associated with APAP

Michael JohnsenThe University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use.  read more

Re-Pharm Uses Cresset’s Forge to Identify Novel Activity for an Existing Drug

Cresset, innovative provider of computational chemistry software and services, announces that its drug discovery arm Re-Pharm Ltd has used Forge to identify novel anti-inflammatory activity for an exi...

What’s Ahead for 2015? Pharm Exec's Industry Outlook

Pharm Exec’s annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead. read more

Russia’s R-Pharm in deals with AbbVie and Bristol-Myers for local production

US drugmaker AbbVie has joined forces with Russia’s R-Pharm to establish the joint production of Kaletra…

Daewon Pharm Co. Ltd. (003220) - Financial and Strategic SWOT Analysis Review

Summary Daewon Pharm Co. Ltd. (Daewon) is a high-tech pharmaceutical company. It undertakes the research, development, manufacturing and marketing of pharmaceutical products. The company offers a wide...

PubMed Articles [3907 Associated PubMed Articles listed on BioPortfolio]

To Conduct Clinical Trial in China, To Go or Not To Go.

In last 10 years, more and more clinical trials have come to China because of potential market/easy access of patient and cost-effectiveness, but looking back, there is less change on the regulatory r...

Editorial board: arch. Pharm. Chem. Life sci. (1/2015).

Cover picture: arch. Pharm. Chem. Life sci. (1/2015).

Unbound Ritonavir Concentrations in Rat and Human Hepatocytes.

Knowledge regarding intracellular drug exposure is crucial to gain mechanistic understanding of hepatic disposition. This study aims to develop an approach to determine unbound intracellular concentra...

In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2/4-p53 interaction.

The interaction of p53 with its negative regulators Mdm2/4 has been widely studied (Khoury and Domling in Curr Pharm Des 18(30):4668-4678, 2012). In p53(+/+) cells, expression of Mdm2/4 leads to p53 t...

Clinical Trials [3402 Associated Clinical Trials listed on BioPortfolio]

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

This open-label, Phase I study will evaluate the safety, tolerability, and pharm acokinetics of increasing doses of GDC-0853 in patients with relapsed or refract ory B-cell non-Hodgkin's l...

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a...

Comparison Study of Intravenous (IV) Versus Oral Iron (Fe) for Iron Deficiency Anemia Treatment in Late Pregnancy

The purpose of this study is to compare the efficacy of treatment between intravenous iron sucrose and oral iron fumarate in pregnant women in the third trimester.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia

This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.

Companies [912 Associated Companies listed on BioPortfolio]

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

cell pharm GmbH


Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...


Pharm-Chem.com is a special directory of the chemical and medicine industries, offering up-to-date information of China chemical and medicine manufacturers and suppliers as well as the news and the la...

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm...

More Information about "cell pharm GmbH" on BioPortfolio

We have published hundreds of cell pharm GmbH news stories on BioPortfolio along with dozens of cell pharm GmbH Clinical Trials and PubMed Articles about cell pharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of cell pharm GmbH Companies in our database. You can also find out about relevant cell pharm GmbH Drugs and Medications on this site too.


Corporate Database Quicklinks

Searches Linking to this Company Record